OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Trial watch: beta-blockers in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Targeting the peripheral neural-tumour microenvironment for cancer therapy
Dan Yaniv, Brandi J. Mattson, Sébastien Talbot, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 780-796
Closed Access | Times Cited: 9
Dan Yaniv, Brandi J. Mattson, Sébastien Talbot, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 780-796
Closed Access | Times Cited: 9
Trial watch: dexmedetomidine in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Anticancer effect of propranolol on diethylnitrosamine‐induced hepatocellular carcinoma rat model
Yomna M. Tamim, Ahmed Nagy, Ahmed M. Abdellah, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 4, pp. 742-757
Closed Access | Times Cited: 7
Yomna M. Tamim, Ahmed Nagy, Ahmed M. Abdellah, et al.
Fundamental and Clinical Pharmacology (2024) Vol. 38, Iss. 4, pp. 742-757
Closed Access | Times Cited: 7
Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review
Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2304-2304
Open Access | Times Cited: 4
Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2304-2304
Open Access | Times Cited: 4
β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress
Szymon Drygała, Michał Radzikowski, Mateusz Maciejczyk
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Szymon Drygała, Michał Radzikowski, Mateusz Maciejczyk
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The place of beta-adrenergic receptor blockers in the treatment of arterial hypertension: From bench-to-bedside
Ashot Avagimyan, Nana Kajaia, Luiza Gabunia, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 10, pp. 102734-102734
Closed Access | Times Cited: 1
Ashot Avagimyan, Nana Kajaia, Luiza Gabunia, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 10, pp. 102734-102734
Closed Access | Times Cited: 1
Drug Repurposing for Cancer Treatment: A Comprehensive Review
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mansour S. Alturki, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12441-12441
Open Access | Times Cited: 1
Harnessing Drug Repurposing to Combat Breast Cancer by Targeting Altered Metabolism and Epithelial-to-Mesenchymal Transition Pathways
Thirukumaran Kandasamy, Shilpi Sarkar, Siddhartha Sankar Ghosh
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3780-3794
Open Access
Thirukumaran Kandasamy, Shilpi Sarkar, Siddhartha Sankar Ghosh
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 12, pp. 3780-3794
Open Access
The β3‐Adrenergic Receptor: Structure, Physiopathology of Disease, and Emerging Therapeutic Potential
Julius T. Dongdem, Axandrah E Etornam, Solomon Beletaa, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
Julius T. Dongdem, Axandrah E Etornam, Solomon Beletaa, et al.
Advances in Pharmacological and Pharmaceutical Sciences (2024) Vol. 2024, Iss. 1
Open Access
Invited Editorial About: “Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal Cancer,” by C. Komine et al.
Devanshi D. Patel, Paxton V. Dickson
Annals of Surgical Oncology (2024)
Open Access
Devanshi D. Patel, Paxton V. Dickson
Annals of Surgical Oncology (2024)
Open Access
